After Record Growth in 2022, Etiometry Paves Way for 2023 Expansion
150+ million hours of data signals, regulatory approvals key to Etiometry’s upward trajectory BOSTON, Mass. – January 31, 2023 – Etiometry, the leader in clinical decision-support software for critical care, today provided a glimpse into its 2023 priorities as well as highlights from 2022, which marked a landmark year of growth for the company – including […]
Read More
Etiometry is the First to Achieve FDA Clearance of an AI-Based Risk Algorithm that Alerts for Inadequate Oxygenation of Adult Patients in Critical Care
U.S. Hospitals can now equip clinicians in adult ICUs with Etiometry’s IDO2 Index™ to rapidly identify changes to patients’ condition. BOSTON, Mass. – January 24, 2023 – Etiometry, a leader in clinical decision-support software, announced today its IDO2 Index™ was cleared for adult use by the Food and Drug Administration. Now, U.S. hospitals can arm adult […]
Read More
Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution
The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, TX. – November 29th, 2022 – Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with the 2022 US Clinical […]
Read More
Etiometry’s Clinical Decision-Support Software Receives CE Mark
This marks the latest regulatory approval for Etiometry as the second adult and third pediatric market authorization October 12, 2022 08:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union’s medical device regulation, marking the […]
Read More
Etiometry Expands AI Software Platform Portfolio with 2 New FDA-Cleared Algorithms for Managing Critical Care Patients
BOSTON, Mass. – July 12, 2022 – Etiometry, a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care. Etiometry is the only critical care AI decision-support company […]
Read More
Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient Outcomes
Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON, Mass. & BREA, Cal. – June 30, 2022 – Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical […]
Read More